Affiliate-supportedIndependent editorialWe never sell medicationSee how
Midwest · Missouri
Local context for Wegovy, Ozempic, Mounjaro, and Zepbound in Kansas City (510,000 residents, 2,200,000 metro). Missouri expanded Medicaid in 2021; KU Health System straddles the state line and serves both Missouri and Kansas patients.
Availability and prices vary by pharmacy and date. We do not maintain real-time per-pharmacy stock data. Confirm with pharmacies directly.
Wegovy
semaglutide · Novo Nordisk
Once-weekly semaglutide injection FDA-approved for chronic weight management in adults and adolescents.
Wegovy in Kansas City →
Ozempic
semaglutide · Novo Nordisk
Once-weekly semaglutide injection FDA-approved for adults with type 2 diabetes.
Ozempic in Kansas City →
Mounjaro
tirzepatide · Eli Lilly
Once-weekly tirzepatide injection FDA-approved for adults with type 2 diabetes.
Mounjaro in Kansas City →
Zepbound
tirzepatide · Eli Lilly
Once-weekly tirzepatide injection FDA-approved for chronic weight management and obstructive sleep apnea.
Zepbound in Kansas City →
Kansas City is a midwest-region city with a population of 510,000 (2,200,000 in the broader metropolitan area). Missouri expanded Medicaid under the Affordable Care Act, which means low-income adults can typically qualify for GLP-1 coverage for type 2 diabetes if the state Medicaid program lists the drug.
Statewide, notable health systems include Barnes-Jewish Hospital, Mercy Health, BJC HealthCare.
Missouri's Medicaid program is MO HealthNet. Coverage rules for GLP-1 medications vary by drug and indication; see our pricing by state map and payer-coverage guides for details.
Cities of similar size with comparable healthcare markets.